Shi Gao Liu
Fortune : 250 M $ au 31/05/2026
Fortune : 250 M $ au 31/05/2026
Dr. Shi Gao Liu is a Chairman & Chief Executive Officer at HanchorBio inc.
Dr. Liu was previously employed as a Chief Executive Office & Executive Director by Shanghai Henlius Biotech, Inc. and a President & Chief Executive Officer by Henlius Biopharmaceuticals, Inc. He received his doctorate degree from Purdue University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HANCHORBIO INC. 40,29 % | 16/10/2025 | 52 458 469 ( 40,29 % ) | 229 M $ | 31/05/2026 |
| 30/06/2025 | 2 410 695 ( 0,7 % ) | 21 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HANCHORBIO INC. | Directeur Général | 11/11/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Fondateur | 30/09/2020 |
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Focuses on development and commercialization of mAb-based therapeutics | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Focuses on development and commercialization of mAb-based therapeutics | Health Technology |
Shanghai Henlius Biotech, Inc.
Shanghai Henlius Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
HanchorBio inc
HanchorBio inc BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national